Publication | Open Access
Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine
20
Citations
24
References
2020
Year
Gln-1062 was considered to be safe and caused fewer gastrointestinal side effects than oral galantamine. Gln-1062 behaved pharmacokinetically as expected and improved performance on cognitive tests.
| Year | Citations | |
|---|---|---|
Page 1
Page 1